Application of diosmin at intrahepatic portal hypertension
Aim of investigation. To study efficacy of phlebodia-600 (diosmin) in treatment of portal hypertension at patients with liver cirrhosis (LC).Methods. Comparative investigation of efficacy of monotherapy by enalapril (10 mg/day) and phlebodia600 (1200 mg/day), and their combination at portal hyperten...
Saved in:
Main Authors: | G. K. Mirodzhov, S. A. Avezov, M. M. Giyasov, S. G. Mirodzhova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2011-02-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1367 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01) -
Principles of portal hypertension treatment at patients with liver cirrhosis
by: Ye. A. Fedosina, et al.
Published: (2012-09-01) -
Experimental methods of portal hypertension studying
by: D. V. Garbuzenko
Published: (2010-04-01) -
Extirpation of rectum for cancer in patient with decompensated liver cirrhosis and portal hypertension
by: P. V. Tsarkov, et al.
Published: (2011-09-01) -
Spontaneous splenic rupture associated with Q fever and portal hypertension: A case report
by: Cecil Mustafiz, et al.
Published: (2025-02-01)